• Mission

    Let's Combat Pain is a website designed as an open forum for patients to share experiences in a worldwide network. We encourage singles and patient groups to become active members in order to increase visibility and share experiences.
    On the "Ask The Expert" area a patient can ask for suggestions and information regarding his case.
    This site, the experts and participants will not provide diagnosis or prescribe medications. We strongly suggest that if needed you consult a professional entity.

    GUIDE – HOW TO POST ON THE FORUM

    GUIDE – HOW TO EDIT PERSONAL PROFILE

    Latest News


    Forum

     

    Please consider registering
    guest

    Log In Register

    Register | Lost password?
    Advanced Search:

    — Forum Scope —



    — Match —



    — Forum Options —




    Wildcard usage:
    *  matches any number of characters    %  matches exactly one character

    Minimum search word length is 4 characters - maximum search word length is 84 characters

    Topic RSS
    Jan M. Keppel Hesselink : Glia, new target for neuropathic pain: palmitoylethanolamide
    26 November 2011
    03:32
    Admin
    Forum Posts: 36
    Member Since:
    7 September 2011
    Offline

    There is a new painkiller available in Germany since november 2011, based on a body own and all natural compound which proved to be effective and without any troublesome side effects, Jan M. Keppel Hesselink, pharmacologist at the Universty of Witten Herdecke (Germany) pointed out at an important medical congres in Italy on November 24-26, 2011. Leading international pain experts, such as the German professor Ralph Baron also spoke at that congres. The compound is already available in Italy, Spain and the Netherlands were many thousands of patients have been treated satisfactorily.

    Keppel hesselink, holding a chair in molecular pharmacology, presented an important breakthrough in chronic pain treatment during the anual neurological congress for Italian anesthesiologists and painspecialists (SAARTI) in Perugia, november 2011. While nearly all painkillers available inhibit pain via the nerve cells, Keppel Hesselink pointed out that a totally different and natural approach via the modulation of the so called glia cells has been overseen. The clinical data he presented supports a new proof of concept (POC), or proof of principle (POP) that focus on non-neuronal targets can lead to significant pain reduction.

    http://www.chronicpaincoalitio…..thic-pa…

    Forum Timezone: UTC 1

    Most Users Ever Online: 104

    Currently Online:
    4 Guest(s)

    Currently Browsing this Page:
    1 Guest(s)

    Member Stats:

    Guest Posters: 2296

    Members: 2524

    Moderators: 0

    Admins: 3

    Forum Stats:

    Groups: 2

    Forums: 6

    Topics: 1653

    Posts: 2341

    Moderators:

    Administrators: admin (6), Zangani (36), Gianluca (0)